L. Poletti

564 total citations
31 papers, 455 citations indexed

About

L. Poletti is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, L. Poletti has authored 31 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in L. Poletti's work include Blood Pressure and Hypertension Studies (14 papers), Hormonal Regulation and Hypertension (6 papers) and Pharmacology and Obesity Treatment (3 papers). L. Poletti is often cited by papers focused on Blood Pressure and Hypertension Studies (14 papers), Hormonal Regulation and Hypertension (6 papers) and Pharmacology and Obesity Treatment (3 papers). L. Poletti collaborates with scholars based in Italy, Germany and France. L. Poletti's co-authors include Annalisa Zoppi, Roberto Fogari, Amedeo Mugellini, C Pasotti, Paola Lusardi, Luca Corradi, Fabio Dall’Olio, Franca Serafini‐Cessi, Gabriella Campadelli‐Fiume and Paola Preti and has published in prestigious journals such as Journal of Virology, Green Chemistry and Journal of Hypertension.

In The Last Decade

L. Poletti

27 papers receiving 403 citations

Peers

L. Poletti
S. De Riu Italy
S. Colman Australia
A. W. D. Leishman United States
Sum Lam United States
Fritz R. B hler Switzerland
Fabio Baschiera Switzerland
S. De Riu Italy
L. Poletti
Citations per year, relative to L. Poletti L. Poletti (= 1×) peers S. De Riu

Countries citing papers authored by L. Poletti

Since Specialization
Citations

This map shows the geographic impact of L. Poletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Poletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Poletti more than expected).

Fields of papers citing papers by L. Poletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Poletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Poletti. The network helps show where L. Poletti may publish in the future.

Co-authorship network of co-authors of L. Poletti

This figure shows the co-authorship network connecting the top 25 collaborators of L. Poletti. A scholar is included among the top collaborators of L. Poletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Poletti. L. Poletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fogari, Roberto, Amedeo Mugellini, Annalisa Zoppi, et al.. (2004). Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. European Journal of Clinical Pharmacology. 59(12). 863–868. 94 indexed citations
2.
Fogari, Roberto, et al.. (2000). MANIDIPINE HAS LESS OEDEMATIGENOUS POTENTIAL THAN AMLODIPINE. Journal of Hypertension. 18. S154–S155. 2 indexed citations
3.
Fogari, Roberto, Annalisa Zoppi, Luca Corradi, et al.. (2000). EFFECT OF DIFFERENT ANGIOTENSIN II ANTAGONISTS ON FIBRINOLYSIS IN HYPERTENSIVE POST-MENOPAUSAL WOMEN. Journal of Hypertension. 18. S155–S155. 1 indexed citations
4.
Fogari, R, Luca Corradi, L. Poletti, et al.. (2000). EFFECTS OF FOSINOPRIL AMLODIPINE COMBINATION ON MICROALBUMINURIA IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES. Journal of Hypertension. 18. S104–S104. 1 indexed citations
5.
Fogari, Roberto, et al.. (1998). Sexual function in hypertensive males treated with lisinopril or atenololA cross-over study. American Journal of Hypertension. 11(10). 1244–1247. 85 indexed citations
6.
Fogari, Roberto, Annalisa Zoppi, Amedeo Mugellini, et al.. (1997). Efficacy of delapril in the treatment of mild to moderate essential hypertension: Evaluation by 24-hour ambulatory blood pressure monitoring. Advances in Therapy. 14(5). 254–261. 10 indexed citations
7.
Fogari, Roberto, Annalisa Zoppi, Paola Lusardi, et al.. (1996). Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of manidipine hydrochloride 10, 20 or 40 mg once daily as compared to placebo in treating mild to moderate essential hypertension: a double-blind, randomized, parallel group, placebo-controlled study.. PubMed. 5. 16–23. 12 indexed citations
8.
Grandi, Andrea, et al.. (1995). Left ventricular anatomy and function in normotensive young adults with hypertensive parentsStudy at rest and during handgrip. American Journal of Hypertension. 8(2). 154–159. 3 indexed citations
9.
Fogari, Roberto, et al.. (1992). Nitrendipine 20 MG Once Daily Versus Nicardipine Slow Release 40 MG Twice Daily in Mild Essential Hypertension: Evaluation by 24-Hour Ambulatory Blood Pressure Monitoring. Clinical and Experimental Hypertension Part A Theory and Practice. 14(4). 587–596. 2 indexed citations
10.
Fogari, Roberto, et al.. (1990). Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease. Cardiovascular Drugs and Therapy. 4(4). 1145–1149. 36 indexed citations
11.
Fogari, Roberto, Annalisa Zoppi, L. Poletti, et al.. (1990). β-Blocker Effects on Plasma Lipids in Antihypertensive Therapy. Journal of Cardiovascular Pharmacology. 16. S76–S80. 13 indexed citations
12.
Fogari, Roberto, et al.. (1990). Benazepril at incremental doses in essential hypertension.. PubMed. 28(2). 63–6. 1 indexed citations
13.
Fogari, Roberto, et al.. (1990). Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.. PubMed. 20(4). 309–15. 1 indexed citations
14.
Fogari, R., et al.. (1989). Community control of hypertension at the worksite in a metallurgical factory: Results of 1-year follow-up. European Journal of Epidemiology. 5(2). 164–169. 1 indexed citations
15.
Fogari, Roberto, et al.. (1988). Rest and Exercise Evaluation of the Antihypertensive Efficacy of Dilevalol and Captopril. Journal of Cardiovascular Pharmacology. 11. S28–S31. 5 indexed citations
16.
Fogari, R., et al.. (1988). [Community control of arterial pressure in industry: the Necchi project for the control of hypertension in the workplace].. PubMed. 78(4). 301–10. 1 indexed citations
17.
Fogari, R., et al.. (1987). Chronic beta 1-blockade and control of left ventricular hypertrophy in hypertension.. PubMed. 25(6). 334–41. 1 indexed citations
18.
Fogari, R., et al.. (1987). [Community control of arterial hypertension in a group of workers in small industries].. PubMed. 78(2). 143–50. 1 indexed citations
19.
Campadelli‐Fiume, Gabriella, L. Poletti, Fabio Dall’Olio, & Franca Serafini‐Cessi. (1982). Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I. Journal of Virology. 43(3). 1061–1071. 61 indexed citations
20.
Gerna, Giuseppe, Paola Franchi, & L. Poletti. (1972). [Evaluation of the antimitotic activity of the rubella virus (virulent Judith strain) on primary and stabilized cell cultures].. PubMed. 48(15). 419–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026